The 20 Largest Medical Device Companies In the World

Share

B. Braun logo No. 16: B. Braun

Melsungen, Germany

www.bbraunusa.com

2016 RANK: 18

Revenue: $7,164,666,842

Fiscal year ending: Dec. 31, 2016

Employees: 58,037

R&D Spend: $322,638,080

 

Key Personnel:

Anna Maria Braun, president, Asia Pacific; Annette Beller, CFO; Heinz-Walter Große, chairman, chief HR officer; Meinrad Lugan, president, hospital care, OPM; Caroll Neubauer, chairman & CEO, B. Braun Medical; Markus Strotmann, president, Avitum; Joachim Schulz, chairman, Aesculap; Bruce Heugel, SVP & CFO, B. Braun Medical; Rob Albert, SVP & chief marketing officer, B. Braun Medical; Joe Grispo Jr., SVP & chief sales officer, B. Braun Medical; Frank Katona, SVP & COO, B. Braun Medical; Cathy Codrea, SVP, general counsel & chief compliance officer, B. Braun Medical; Dr. Wes Cetnarowski, SVP, scientific affairs & CMO, B. Braun Medical

Description:

B. Braun has seen a flurry of product releases this year, launching its Easypump home infusion app, Diacap Pro Dialyzer, Protosan wound gel, Actreen urological mini catheters, the Docit and HubScrub sterilization devices and its Flow Collector ostomy device.

B. Braun also announced the integration of its Outlook large-volume infusion pumps with Iatric Systems Accelero Connect software, clearing the device to communicate with a number of electronic health record systems.

The company has also continued its focus on partnership, collaboration and profitability. Braun and Christie Medical said they plan to combine the VeinViewer system with Braun’s line of IV products to enhance the ease and safety of peripheral IV catheters.

Download the full Big 100 list here.

And you can also pick up a free hard copy of the Big 100 issue at DeviceTalks Boston on Oct. 2!

Next>>

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.


Register now with the code "TAVR" and save 15% today.

Pages: 1 2 3 4 5 6 7 8 9 10 11

Comments

  1. Chris Newmarker says:

    Apologies. We had to fix a technical glitch with the Big 100 spreadsheet download. If you fill out the sign-up form now, you should get an email with a link to download the spreadsheet, instead of last year’s Big 100 edition.

  2. Chris, Thank you for the update. I just downloaded the Big 100.

Speak Your Mind

*